Patients typically transition to ESKD at a median age of 75 years, with a favorable renal prognosis compared to ADTKD-UMOD and ADTKD-MUC1 [79]. The gene discussed is MUC1; the disease is autosomal dominant medullary cystic kidney disease with or without hyperuricemia.